Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
MARSEILLE, France–(BUSINESS WIRE)–#ANKET–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”)... Read more.
Forrester Opens Nominations For Its 2025 B2B Awards In EMEA And APAC
Awards honor B2B organizations that drive revenue growth through effective alignment of marketing, sales, and product strategies LONDON–(BUSINESS WIRE)–Forrester... Read more.
Klaviyo Announces Pricing of Secondary Offering of 10,969,078 Shares of Series A Common Stock by Andrew Bialecki
BOSTON–(BUSINESS WIRE)–Klaviyo, Inc. (the “Company”) (NYSE: KVYO), the only CRM built for consumer brands, today announced the pricing of an underwritten... Read more.
ANEXT Bank Recorded S$44.9M Revenue in 2024, up 83.5%
The bank also saw a 207% increase in deposits and 280% increase in loans SINGAPORE–(BUSINESS WIRE)–ANEXT Bank, a Singapore digital wholesale bank licensed... Read more.
Li-Cycle Obtains Creditor Protection Under CCAA and Chapter 15
Company enters into $10.5 million debtor-in-possession financing facility (“DIP Facility”) term sheet with Glencore Li-Cycle and Glencore agree to “stalking... Read more.
Microba Announces Landmark GI Study Results From Over 4,600 Patients
Results at a glance: 71.4% of MetaXplore™ reports from 4,616 patients identified actionable results 41.9% tested positive for abnormal microbiome markers linked... Read more.
Bloomstreet Enters into Strategic Partnership Agreement with Google Israel for Market Expansion in Japan
Optimizing Global Websites for the Japanese Visitors: Detailed UX/UI Adaptation, Comprehensive Japanese Localization, Extensive Localization and Cultural Relevance... Read more.
Renatus Tactical Acquisition Corp I Announces Pricing of Upsized $210 Million Initial Public Offering
CORAL GABLES, Fla.–(BUSINESS WIRE)–Renatus Tactical Acquisition Corp I (the “Company”) today announced the pricing of its upsized initial public... Read more.
Rubedo Life Sciences’ Drug Discovery Platform, ALEMBIC™, Helps Identify Senescent or “Zombie” Neurons in New Study Linking Neuropathic Pain and Aging Published in Peer-Reviewed Scientific Journal Nature Neuroscience
Study is the first demonstration of senescent neurons driving neuropathic pain1 Rubedo’s proprietary, AI-driven drug discovery platform ALEMBIC™ identified senescent... Read more.
Best’s Market Segment Report: AM Best Maintains Outlook on Philippine Non-Life Insurance Segment at Stable
SINGAPORE–(BUSINESS WIRE)–#insurance—AM Best has maintained its market segment outlook on the Philippine non-life insurance market at stable, citing... Read more.